Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, addresses roadblocks to cancer screenings first thrown up by the COVID-19 pandemic in 2020 and that continue to reverberate today.
Although numbers of cancer screenings are improving, they remain down, and these screenings are delayed because the issue is multifaceted: There is diminished capacity to handle screening requests, staffing issues, and social distancing, so that even people who are ready and want to get screened still are delayed in doing so, noted Debra Patt, MD, PhD, MBA, executive vice president of Texas Oncology, when addressing roadblocks to cancer screenings first thrown up by the COVID-19 pandemic that continue still.
Transcript
Is there any sign that cancer screenings are returning to prepandemic levels?
Cancer screening has been substantially impacted by the pandemic. We know that, as we published early in 2020, that in 2020, rates were dramatically down across the board for breast, colon, prostate, and lung cancer screenings. We have seen levels improve, but they have not yet returned to normal. In fact, so much so that there are delays in even people that want to get screening getting screened. There’s a multifaceted issue that people are still delaying screenings and there is diminished capacity in each place that does cancer screening, to some degree because of social distancing, to some degree because of staffing. And they just can’t flex to accommodate all the people that have delayed, even if they were all ready to go get screened. No, things have not returned to normal, it still does remain a problem, but it’s much better than we saw in 2020.
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
New Insights Into Meth-Associated PAH Care Gaps: Anjali Vaidya, MD, on Closing the Divide
June 4th 2025Research from Anjali Vaidya, MD, FACC, FASE, FACP, Temple University Hospital, reveals critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.
Read More
Laundromats as a New Frontier in Community Health, Medicaid Outreach
May 29th 2025Lindsey Leininger, PhD, and Allister Chang, MPA, highlight the potential of laundromats as accessible, community-based settings to support Medicaid outreach, foster trust, and connect families with essential health and social services.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
2 Commerce Drive
Cranbury, NJ 08512